Parma, Italy

Gino Villetti

USPTO Granted Patents = 10 

 

 

Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 38(Granted Patents)


Company Filing History:


Years Active: 2000-2018

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Gino Villetti: Innovator in Pharmaceutical Chemistry

Introduction

Gino Villetti is a prominent inventor based in Parma, Italy. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 10 patents. His work primarily focuses on developing innovative compounds that target various medical conditions.

Latest Patents

Among his latest patents, Villetti has developed derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors. These compounds are particularly useful in treating conditions such as Chronic Obstructive Pulmonary Disease (COPD). Another notable patent involves 1-(2-fluorobiphenyl-4-yl)-alkyl carboxylic acid derivatives, which are capable of stabilizing the tetrameric native state of transthyretin for the prophylaxis and treatment of amyloidosis.

Career Highlights

Gino Villetti is currently associated with Chiesi Farmaceutici S.p.A., a leading pharmaceutical company. His work at Chiesi has allowed him to focus on innovative drug development, contributing to advancements in therapeutic options for patients.

Collaborations

Villetti has collaborated with notable colleagues in his field, including Bruno Pietro Imbimbo and Andrea Rizzi. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Gino Villetti's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the treatment of various medical conditions, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…